A study has shown that the Moderna Covid vaccine generates more than double the antibodies of a similar shot by Pfizer and BioNTech SE in research directly comparing immune responses to the inoculations. Major research carried at a Belgian hospital showed that the antibody levels of individuals w
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp